KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (ONC) Receivables - Net (2017 - 2025)

Historic Receivables - Net for BeOne Medicines (ONC) over the last 9 years, with Q3 2025 value amounting to $863.3 million.

  • BeOne Medicines' Receivables - Net rose 5170.64% to $863.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $863.3 million, marking a year-over-year increase of 5170.64%. This contributed to the annual value of $676.3 million for FY2024, which is 8889.02% up from last year.
  • Per BeOne Medicines' latest filing, its Receivables - Net stood at $863.3 million for Q3 2025, which was up 5170.64% from $770.8 million recorded in Q2 2025.
  • In the past 5 years, BeOne Medicines' Receivables - Net ranged from a high of $863.3 million in Q3 2025 and a low of $73.8 million during Q2 2021
  • In the last 5 years, BeOne Medicines' Receivables - Net had a median value of $309.6 million in 2023 and averaged $386.0 million.
  • Its Receivables - Net has fluctuated over the past 5 years, first surged by 69981.62% in 2021, then tumbled by 6415.58% in 2022.
  • Quarter analysis of 5 years shows BeOne Medicines' Receivables - Net stood at $483.1 million in 2021, then tumbled by 64.16% to $173.2 million in 2022, then skyrocketed by 106.75% to $358.0 million in 2023, then skyrocketed by 88.89% to $676.3 million in 2024, then grew by 27.65% to $863.3 million in 2025.
  • Its Receivables - Net stands at $863.3 million for Q3 2025, versus $770.8 million for Q2 2025 and $717.2 million for Q1 2025.